Role of clinical evaluation committees in sepsis trials: from 'valid cohort' assessment to subgroup analysis (Q39979975)

16 September 2017

Role of clinical evaluation committees in sepsis trials: from 'valid cohort' assessment to subgroup analysis (English)

1 reference

16 September 2017

0 references

Jean-François Dhainaut

series ordinal

1

1 reference

PMCID

2689452

16 September 2017

language of work or name

1 reference

18 March 2009

1 reference

16 September 2017

1 reference

16 September 2017

13

1 reference

16 September 2017

2

1 reference

16 September 2017

124

1 reference

https://scigraph.springernature.com/pub.10.1186/cc7686

16 September 2017

0 references

cites work

A clinical evaluation committee assessment of recombinant human tissue factor pathway inhibitor (tifacogin) in patients with severe community-acquired pneumonia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2689452

Severe community-acquired pneumonia as a cause of severe sepsis: data from the PROWESS study

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2689452

Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2689452

Efficacy and safety of recombinant human activated protein C for severe sepsis

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2689452

Clinical trials for severe sepsis. Past failures, and future hopes

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2689452

International sepsis trial (INTERSEPT): role and impact of a clinical evaluation committee

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2689452

Confirmatory interleukin-1 receptor antagonist trial in severe sepsis: a phase III, randomized, double-blind, placebo-controlled, multicenter trial. The Interleukin-1 Receptor Antagonist Sepsis Investigator Group

25 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2689452

Treatment of gram-negative bacteremia and septic shock with HA-1A human monoclonal antibody against endotoxin. A randomized, double-blind, placebo-controlled trial. The HA-1A Sepsis Study Group

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2689452

Platelet-activating factor receptor antagonist BN 52021 in the treatment of severe sepsis: a randomized, double-blind, placebo-controlled, multicenter clinical trial. BN 52021 Sepsis Study Group.

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2689452

Efficacy and safety of monoclonal antibody to human tumor necrosis factor alpha in patients with sepsis syndrome. A randomized, controlled, double-blind, multicenter clinical trial. TNF-alpha MAb Sepsis Study Group.

20 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2689452

International integrated database for the evaluation of severe sepsis and drotrecogin alfa (activated) therapy: analysis of efficacy and safety data in a large surgical cohort

20 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2689452

Reassessing recombinant human activated protein C for sepsis: time for a new randomized controlled trial

4 November 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/19439041

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Prophylactic heparin in patients with severe sepsis treated with drotrecogin alfa (activated)

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/19439041

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

International integrated database for the evaluation of severe sepsis (INDEPTH): clinical evaluation committee report on the safety of drotrecogin alfa (activated) therapy

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/19439041

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1186/CC7686

1 reference

PMCID

2689452

Dimensions Publication ID

16 September 2017

0 references

1 reference

16 September 2017

1 reference

PMCID

2689452